Neurogenetics, Development and Evolution
|
| |
ALESSANDRA D'AZZO, Ph.D.
- Member
- Genetics / Tumor Cell Biology
- St. Jude Children's Research Hospital
- Affiliated Professor
- Department of Anatomy and Neurobiology
- The University of Tennessee College of Medicine
Address
- St. Jude Children's Research Hospital
- Department of Genetics
- Memphis, TN 38105
Education
- Ph.D. Institution: University of Milano, Milan Italy; Erasmus University, Rotterdam, The Netherlands
Research Interests
The primary scope of this research program is to elucidate the fundamental role of the lysosomal system in normal cellular metabolism and in pathological conditions associated with lysosomal storage disorders (LSD).
Using a combination of molecular, genetic, and biochemical approaches, they have identified a multiprotein complex of three lysosomal hydrolases: protective protein/cathepsin A (PPCA), -galactosidase (-Gal), and neuraminidase (Neur). In the complex, PPCA (a serine carboxypeptidase) directly associates with the two glycosidases, a configuration needed for their intracellular routing, lysosomal activity, and stability. Three genetically distinct, human neurodegenerative LSD are caused by either single or combined deficiency of these enzymes: galactosialidosis, GM1-gangliosidosis, and sialidosis. To date, there is no effective therapy for these diseases. Using both in vitro systems and laboratory animals, they investigate the cell-specific expression and regulation of these enzymes, their intracellular trafficking, mode/site of association and activation, and their interaction with the substrates they cleave. They are also developing new therapeutic strategies in animal models for the future treatment of patients with these LSD. Greater knowledge of the function of these and other lysosomal proteins in the normal lysosome, as well as a better understanding of the structural and biochemical basis of the diseases, will aid in the design of new drugs and therapies.
The experimental approaches include: generation and characterization of knockout and transgenic mice; correction of affected mice by transplantation with transgenic over expressing or retrovirally transduced bone marrow; expression and regulation of normal and mutant enzymes in prokaryotic/eukaryotic cell systems; and crystal structure determination of over expressed proteins.
Links
- St Jude Faculty - Alessandra d'Azzo
Recent Publications
- Caciotti A, Di Rocco M, Filocamo M, Grossi S, Traverso F, d'Azzo A, Cavicchi
C, Messeri A, Guerrini R, Zammarchi E, Donati MA, Morrone A.
Type II sialidosis: review of the clinical spectrum and identification of a new
splicing defect with chitotriosidase assessment in two patients.
J Neurol. 2009 Jul 1; [Epub ahead of print]
PMID: 19568825
- Wang D, Zaitsev S, Taylor G, d'Azzo A, Bonten E.
Protective Protein/Cathepsin A Rescues N-glycosylation defects in
Neuraminidase-1.
Biochim Biophys Acta. 2009 Jan 26; [Epub ahead of print]
PMID: 19364485
- Zanoteli E, Vergani N, Campos Y, Vainzof M, Oliveira AS, d'Azzo A.
Mitochondrial alterations in dynamin 2-related centronuclear myopathy.
Arq Neuropsiquiatr. 2009 Mar;67(1):102-4. No abstract available.
PMID: 19330221
- Kiss A, Zen PR, Bittencourt V, Paskulin GA, Giugliani R, d'Azzo A, Schwartz
IV.
A Brazilian galactosialidosis patient given renal transplantation: A case
report.
J Inherit Metab Dis. 2008 Oct 21; [Epub ahead of print]
PMID: 18937050
- Starcher B, d'Azzo A, Keller PW, Rao GK, Nadarajah D, Hinek A.
Neuraminidase-1 is required for the normal assembly of elastic fibers.
Am J Physiol Lung Cell Mol Physiol. 2008 Oct;295(4):L637-47. Epub 2008 Aug 8.
PMID: 18689602
- Yogalingam G, Bonten EJ, van de Vlekkert D, Hu H, Moshiach S, Connell SA,
d'Azzo A.
Neuraminidase 1 is a negative regulator of lysosomal exocytosis.
Dev Cell. 2008 Jul;15(1):74-86.
PMID: 18606142
view complete list of references (pubmed link)
|
|
|